We are live on
!
Find out more
HCG
Haven Capital Group Portfolio holdings
AUM
$125M
1-Year Est. Return
30.81%
This Fund
S&P 500
This Quarter
Est. Return
+3.18%
1 Year Est. Return
+30.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$5.68M
(-5.1%)
Cap. Flow
-$8.29M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
73.8%
Holding
37
New
–
Increased
8
Reduced
24
Closed
3
Avg Time Held
3.6
quarters
Top 10 Avg Time Held
2.8
quarters
Top 20 Avg Time Held
3.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$606K |
| 2 |
Vertiv
VRT
|
+$223K |
| 3 |
Kinross Gold
KGC
|
+$186K |
| 4 |
Visa
V
|
+$105K |
| 5 |
Amazon
AMZN
|
+$15.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.64M |
| 2 |
Apple
AAPL
|
+$1.22M |
| 3 |
Idexx Laboratories
IDXX
|
+$1.04M |
| 4 |
Intuitive Surgical
ISRG
|
+$867K |
| 5 |
Roper Technologies
ROP
|
+$788K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.34% |
| 2 | Healthcare | 20.96% |
| 3 | Consumer Discretionary | 7.97% |
| 4 | Industrials | 3.86% |
| 5 | Materials | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Skyworks Solutions
SWKS
$12.2B
| $361K | 0.34% |
5,698
-2,262
| -28% | -$158K |
2024 Q4
4 quarters
|
|
27
Zebra Technologies
ZBRA
$18.1B
| $338K | 0.32% |
1,390
-189
| -12% | -$50.5K |
2024 Q4
4 quarters
|
|
28
Gilead Sciences
GILD
$182B
| $335K | 0.31% |
2,730
-1,257
| -32% | -$153K |
2024 Q4
4 quarters
|
|
29
Bristol-Myers Squibb
BMY
$122B
| $325K | 0.3% |
6,023
-1,816
| -23% | -$87.4K |
2024 Q4
4 quarters
|
|
30
Eli Lilly
LLY
$1.04T
| $267K | 0.25% |
248
-55
| -18% | -$52.6K |
2025 Q1
3 quarters
|
|
31
Expeditors International
EXPD
$25.2B
| $249K | 0.23% |
1,670
| – | – |
2025 Q3
1 quarter
|
|
32
Southern Company
SO
$99.1B
| $246K | 0.23% |
2,825
| – | – |
2024 Q4
4 quarters
|
|
33
Emerson Electric
EMR
$88.7B
| $201K | 0.19% |
1,517
-583
| -28% | -$77.3K |
2024 Q4
4 quarters
|
|
34
Iovance Biotherapeutics
IOVA
$6.03B
| $161K | 0.15% |
59,143
-16,361
| -22% | -$37.9K |
2024 Q4
4 quarters
|
|
35
Nike
NKE
$51.6B
| – | – |
-7,480
| Closed | -$522K | – |
|
36
Norfolk Southern
NSC
$71.2B
| – | – |
-701
| Closed | -$211K | – |
|
37
Verizon
VZ
$193B
| – | – |
-4,786
| Closed | -$210K | – |
|
Similar funds
EIP
KSB
PWM
CHWM
KWM
CFM
BVP
MFS
Haven Capital Group's Q4 2025 Portfolio in Review
As of Q4 2025, Haven Capital Group held 37 positions worth $107M, down 5.1% from $112M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Haven Capital Group withdrew a net $8.29M in Q4 2025, closing 3 positions and reducing 24 holdings. Its most notable exit was Nike, an estimated $522K position sold in full.
By sector, the portfolio is most concentrated in Technology at 59% of assets, down from 61% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Haven Capital Group added an estimated $606K to Meta Platforms (Facebook).
- Haven Capital Group added most to Meta Platforms (Facebook) in Q4 2025, an estimated $606K increase.
- Haven Capital Group's biggest Q4 2025 reduction was Broadcom, cutting an estimated $1.64M.
- Haven Capital Group fully exited Nike in Q4 2025, selling an estimated $522K.
- Haven Capital Group's ten largest holdings make up 74% of its $107M portfolio in Q4 2025.
- Haven Capital Group opened 0 new positions and closed 3 in Q4 2025.
- Haven Capital Group's portfolio value fell 5.1% quarter-over-quarter to $107M.
Based on Haven Capital Group's 13F filing for Q4 2025, filed 15 Jan 2026.